Literature DB >> 15776463

The role of RhoA in the regulation of cell morphology and motility.

Vadim Tkach1, Elisabeth Bock, Vladimir Berezin.   

Abstract

Members of the Rho family of small GTPases are key regulators of the actin cytoskeleton, particularly in relation to the cell shape changes and the adhesion dynamic that drive cell migration. Here, we report the effect of activation or inhibition of the function of RhoA on cell motility and morphology. Both in the presence and the absence of serum, expression of constitutively active RhoA dramatically inhibited L929 fibroblasts' cell motility, and induced a rounding of the cells and a decrease in the number of processes per cell. In contrast, expression of a dominant negative mutant of RhoA had no effect on cell motility or morphology in steady-state conditions with or without serum in the medium. Inhibition of p160ROCK, a kinase effector of RhoA, only partially inhibited cell migration. Conversely, when cells were submitted to a period of serum deprivation followed by addition of serum, inhibition of endogenous RhoA by expression of the dominant negative mutant of RhoA impeded cell motility after serum stimulation. Thus, RhoA activity is required for stimulation of cell locomotion by serum factors. It was also observed that the addition of serum factors to quiescent L929 and NR6wtEGFR fibroblasts resulted in a delayed motility response of several hours compared to the immediately induced morphological changes, indicating the absence of a previously assumed direct correlation between changes in cell motility and cell morphology in response to serum addition. The motility response of L929 and NR6wtEGFR fibroblasts to serum stimulation required protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15776463     DOI: 10.1002/cm.20062

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  17 in total

1.  Modulation of chondrocyte motility by tetrahedral DNA nanostructures.

Authors:  Sirong Shi; Shiyu Lin; Xiaoru Shao; Qianshun Li; Zhang Tao; Yunfeng Lin
Journal:  Cell Prolif       Date:  2017-08-09       Impact factor: 6.831

2.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.

Authors:  Bassem D Khalil; Samer Hanna; Bechara A Saykali; Sally El-Sitt; Anita Nasrallah; Daniel Marston; Marwan El-Sabban; Klaus M Hahn; Marc Symons; Mirvat El-Sibai
Journal:  Exp Cell Res       Date:  2013-12-10       Impact factor: 3.905

Review 3.  RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets.

Authors:  Zhenhan Deng; Yiming Jia; Haifeng Liu; Miao He; Yuntao Yang; Wenfeng Xiao; Yusheng Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 4.  Targeting the PI3K pathway for cancer therapy.

Authors:  Navid Sadeghi; David E Gerber
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

5.  Effects of constitutively active GTPases on fibroblast behavior.

Authors:  Z-G Zhang; C A Lambert; S Servotte; G Chometon; B Eckes; T Krieg; C M Lapière; B V Nusgens; M Aumailley
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  The Breast Cancer Susceptibility Gene Product (γ-Synuclein) Alters Cell Behavior through its [corrected] Interaction with Phospholipase Cβ.

Authors:  V Siddartha Yerramilli; Suzanne Scarlata
Journal:  Cell Signal       Date:  2015-10-28       Impact factor: 4.315

7.  The EphA4 Signaling is Anti-catabolic in Synoviocytes but Pro-anabolic in Articular Chondrocytes.

Authors:  Virginia M Stiffel; Alexander Thomas; Charles H Rundle; Matilda H-C Sheng; Kin-Hing William Lau
Journal:  Calcif Tissue Int       Date:  2020-08-20       Impact factor: 4.333

8.  Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma.

Authors:  Pei-Suen Tsou; M Asif Amin; Phillip L Campbell; George Zakhem; Beatrix Balogh; Gautam Edhayan; Ray A Ohara; Elena Schiopu; Dinesh Khanna; Alisa E Koch; David A Fox
Journal:  J Invest Dermatol       Date:  2015-08-19       Impact factor: 8.551

9.  Plasticity in the macromolecular-scale causal networks of cell migration.

Authors:  John G Lock; Mehrdad Jafari Mamaghani; Hamdah Shafqat-Abbasi; Xiaowei Gong; Joanna Tyrcha; Staffan Strömblad
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.

Authors:  Samer Hanna; Bassem Khalil; Anita Nasrallah; Bechara A Saykali; Rania Sobh; Selim Nasser; Mirvat El-Sibai
Journal:  Int J Oncol       Date:  2014-03-07       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.